Telemetry Investments’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Telemetry Investments’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$407K	Buy	11,500 +5,550	+93%	+$667K	0.64%	42
2022 Q3	$1.34M	Sell	5,950 -3,314	-36%	-$815K	1.72%	9
2022 Q2	$1.75M	Buy	9,264 +2,164	+30%	+$436K	2.07%	6
2022 Q1	$1.77M	Sell	7,100 -1,733	-20%	-$274K	2.79%	5
2021 Q4	$1.38M	Buy	8,833 +2,329	+36%	+$450K	1.77%	8
2021 Q3	$1.3M	Buy	6,504 +1,318	+25%	+$313K	1.76%	13
2021 Q2	$1.32M	Buy	5,186 +170	+3%	+$42.4K	1.82%	13
2021 Q1	$1.33M	Buy	5,016 +721	+17%	+$227K	1.51%	18
2020 Q4	$1.58M	Buy	4,295 +151	+4%	+$43.3K	2.68%	5
2020 Q3	$1.01M	Sell	4,144 -1,023	-20%	-$318K	2.2%	12
2020 Q2	$1.49M	Buy	5,167 +455	+10%	+$134K	4.04%	5
2020 Q1	$961K	Buy	4,712 +184	+4%	+$58.6K	3.36%	5
2019 Q4	$2.02M	Sell	4,528 -2,706	-37%	-$960K	6.74%	5
2019 Q3	$2.23M	Sell	7,234 -5,301	-42%	-$1.72M	6.42%	3
2019 Q2	$3.99M	Buy	12,535 +7,797	+165%	+$2.7M	3.08%	8
2019 Q1	$1.99M	Sell	4,738 -342	-7%	-$137K	1.01%	19
2018 Q4	$1.55M	Buy	5,080 +3,813	+301%	+$1.23M	0.99%	24
2018 Q3	$456K	Sell	1,267 -33	-3%	-$11.3K	0.21%	65
2018 Q2	$476K	Buy	+1,300	New	+$463K	0.18%	63

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Telemetry Investments's EIGR Position: Q4 2022 in Review

Telemetry Investments increased its Eiger BioPharmaceuticals, Inc. (EIGR) stake by 93% in Q4 2022, buying an estimated $667K and bringing the position to 11,500 shares worth $407K. The position accounts for 0.64% of the portfolio, ranked #42.

Telemetry Investments first reported a position in EIGR in Q2 2018 and has held it in 19 quarters since. The position peaked at $3.99M in Q2 2019. 81 funds tracked by Wall St. Rank hold EIGR as of Q4 2022.

Telemetry Investments held 11,500 shares of Eiger BioPharmaceuticals, Inc. worth $407K as of Q4 2022.
Telemetry Investments bought 5,550 Eiger BioPharmaceuticals, Inc. shares in Q4 2022, an estimated $667K.
Eiger BioPharmaceuticals, Inc. made up 0.64% of Telemetry Investments's portfolio in Q4 2022, its #42 holding.
Telemetry Investments first reported a position in Eiger BioPharmaceuticals, Inc. in Q2 2018 and has held it in 19 quarters since.
Telemetry Investments's Eiger BioPharmaceuticals, Inc. position peaked at $3.99M in Q2 2019.
81 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.